{"gene":"RCAN1","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2000,"finding":"RCAN1 (DSCR1) physically interacts with and inhibits calcineurin A (the catalytic subunit of PP2B/calcineurin). The RCAN1 binding region in calcineurin A is located in the linker region between the catalytic domain and the calcineurin B binding domain, outside other previously defined functional domains. Overexpression of RCAN1 inhibits calcineurin-dependent gene transcription through inhibition of NFAT nuclear translocation.","method":"Co-immunoprecipitation, functional transcription assays, domain mapping","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal binding, domain mapping, and functional transcriptional readout; replicated across multiple subsequent studies","pmids":["10861295"],"is_preprint":false},{"year":2006,"finding":"DSCR1 (RCAN1) and DYRK1A act synergistically to prevent nuclear occupancy of NFATc transcription factors. Mathematical modelling and mouse genetic experiments (calcineurin- and Nfatc-deficient mice, Dscr1- and Dyrk1a-overexpressing mice) show that 1.5-fold increase in dosage of DSCR1 and DYRK1A cooperatively destabilizes the NFAT regulatory circuit.","method":"Genetic mouse models (KO, transgenic overexpression), mathematical modelling, nuclear localization assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal genetic and biochemical approaches, high-citation foundational study","pmids":["16554754"],"is_preprint":false},{"year":2009,"finding":"RCAN1 suppresses VEGF-mediated angiogenic signaling by inhibiting the calcineurin pathway in endothelial cells. A single extra transgenic copy of Dscr1 suppresses tumor growth through a deficit in tumor angiogenesis. Additionally, RCAN1 and DYRK1A together may markedly diminish angiogenesis.","method":"Transgenic mouse models, tumor xenograft assays, genetic KO experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 — multiple mouse models with defined cellular phenotype (angiogenesis suppression), high-citation study","pmids":["19458618"],"is_preprint":false},{"year":2004,"finding":"DSCR1 (RCAN1) is a VEGF target gene in endothelial cells. DSCR1 expression blocks dephosphorylation, nuclear translocation, and transcriptional activity of NFAT, forming a negative feedback loop with calcineurin signaling. Knockdown of endogenous DSCR1 increases NFAT activity and stimulates expression of inflammatory genes (tissue factor, E-selectin, Cox-2).","method":"siRNA knockdown, NFAT reporter assays, genome-wide gene expression analysis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain- and loss-of-function with defined molecular readouts","pmids":["15016650"],"is_preprint":false},{"year":2009,"finding":"RCAN1 interacts with TAB2 (identified by yeast two-hybrid screen), recruiting TAK1, TAB1, and calcineurin into a macromolecular signalling complex. TAK1 phosphorylates RCAN1 at Ser94 and Ser136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signalling and enhancing NFATc1 nuclear translocation and cardiomyocyte hypertrophic growth. Calcineurin activation in turn dephosphorylates and inhibits TAK1 and TAB1.","method":"Yeast two-hybrid, Co-IP, in vitro phosphorylation assay, MEF KO cultures, cardiomyocyte hypertrophy assay","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — yeast two-hybrid identification confirmed by Co-IP, in vitro kinase assay with site-specific mutagenesis, genetic KO validation","pmids":["19136967"],"is_preprint":false},{"year":2011,"finding":"Dyrk1A directly interacts with and phosphorylates RCAN1 at Ser112 and Thr192. Dyrk1A-mediated phosphorylation at Ser112 primes RCAN1 for GSK3β-mediated phosphorylation at Ser108. Phosphorylation at Thr192 enhances RCAN1 binding to calcineurin, potentiating its inhibitory activity, leading to reduced NFAT transcriptional activity and enhanced tau phosphorylation.","method":"In vitro kinase assay, co-immunoprecipitation, site-directed mutagenesis, NFAT reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with mutagenesis and functional downstream readouts","pmids":["21965663"],"is_preprint":false},{"year":2005,"finding":"A small peptide fragment of DSCR1 competitively inhibits calcineurin phosphatase activity in vitro and in vivo, identifying the minimal calcineurin-inhibitory domain of RCAN1.","method":"In vitro calcineurin activity assay, in vivo inhibition assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with defined peptide fragment","pmids":["16131541"],"is_preprint":false},{"year":2008,"finding":"Targeted deletion of both DSCR1 isoforms leads to hyperactivated calcineurin and precocious endothelial apoptosis, inhibiting formation of an effective tumor vasculature. Pharmacological calcineurin inhibition (cyclosporin A) rescues the endothelial defect in DSCR1-/- mice, restoring tumor growth. The DSCR1.Ex4 isoform suppresses calcineurin-NFAT signaling blocking endothelial proliferation, while the DSCR1.Ex1 isoform may promote angiogenesis.","method":"Genetic KO mouse model, tumor xenograft, pharmacological rescue with cyclosporin A","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — KO with defined cellular phenotype, isoform-specific effects, pharmacological epistasis","pmids":["18455125"],"is_preprint":false},{"year":2007,"finding":"RCAN1 knockout mice exhibit deficits in spatial learning and memory, reduced associative cued memory, and impaired late-phase LTP, phenotypes similar to transgenic mice with increased calcineurin activity. RCAN1 KO mice display increased calcineurin activity, increased abundance of a cleaved calcineurin fragment, and decreased phosphorylation of the calcineurin substrate DARPP-32.","method":"RCAN1 knockout mouse behavioral testing, electrophysiology (L-LTP), calcineurin activity assay, western blotting","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple behavioral, electrophysiological, and biochemical readouts","pmids":["18045910"],"is_preprint":false},{"year":2009,"finding":"RCAN1 protein is degraded through two distinct pathways: the ubiquitin proteasome pathway and chaperone-mediated autophagy (CMA). Two CMA recognition motifs were identified in the RCAN1 protein. Inhibition of RCAN1 degradation reduces calcineurin-NFAT activity.","method":"Lysosomal inhibitor assays, macroautophagy inhibition, CMA disruption, promoter assay","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — multiple pharmacological approaches with functional readout; single lab","pmids":["19509306"],"is_preprint":false},{"year":2008,"finding":"RCAN1 is a novel ATF6-inducible gene. Activated ATF6 induces RCAN1 promoter activity, upregulates RCAN1 mRNA, inhibits calcineurin phosphatase activity, and exerts a growth-modulating effect in cardiac myocytes that is inhibited by RCAN1-targeted siRNA, linking ER stress signaling to calcineurin-NFAT pathway regulation.","method":"ATF6 transgenic mouse model, adenoviral overexpression, RCAN1 promoter-reporter assay, siRNA knockdown, calcineurin activity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo transgenic model combined with cell-based promoter assay, siRNA knockdown, and enzymatic activity assay","pmids":["18319259"],"is_preprint":false},{"year":2008,"finding":"RCAN1/DSCR1 regulates vesicle exocytosis and fusion pore kinetics in chromaffin cells. Rcan1 controls the number of vesicles undergoing exocytosis and the speed at which the vesicle fusion pore opens and closes, independent of Ca2+ entry or readily releasable vesicle pool size. Acute calcineurin inhibition did not replicate the effect of RCAN1 overexpression.","method":"Carbon fibre amperometry in chromaffin cells from Rcan1 KO and RCAN1-overexpressing mice","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — direct electrophysiological measurement in complementary KO and overexpression models","pmids":["18180251"],"is_preprint":false},{"year":2011,"finding":"RCAN1 overexpression in primary neurons activates caspase-9 and caspase-3, inducing neuronal apoptosis. This neurotoxicity is inhibited in caspase-3 knockout neurons. RCAN1-1 expression can be activated by dexamethasone through a functional glucocorticoid response element in the RCAN1-1 promoter.","method":"Primary neuron transfection, caspase activation assay, caspase-3 KO neurons, promoter reporter assay, ChIP","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — gain-of-function with genetic KO rescue and defined apoptotic pathway","pmids":["21216952"],"is_preprint":false},{"year":2012,"finding":"RCAN1 (DSCR1) interacts with FMRP and regulates both dendritic spine morphogenesis and local protein synthesis. Decreasing FMRP levels restores the DSCR1-induced changes in dendritic spine morphology, placing DSCR1 as a novel regulator of FMRP.","method":"Co-immunoprecipitation, dendritic spine imaging, local protein synthesis assay, genetic epistasis","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP with functional spine morphology and protein synthesis readouts, single lab","pmids":["22863780"],"is_preprint":false},{"year":2011,"finding":"RCAN1 increases the expression and activity of GSK-3β at a post-transcriptional level. RCAN1-1S isoform correlates with GSK-3β levels in human brain, suggesting RCAN1 modulates the calcineurin-GSK-3β equilibrium.","method":"Tet-off regulated RCAN1 transgene, Western blotting, microarray, isoform-specific analysis","journal":"The FEBS journal","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, regulated transgene expression with Western blot readout; no direct mechanistic link established","pmids":["16649988"],"is_preprint":false},{"year":2012,"finding":"Amyloid-β upregulates RCAN1 expression through oxidative stress. RCAN1 proteins then inhibit calcineurin (a tau phosphatase) and induce expression of GSK-3β (a tau kinase), linking Aβ toxicity to tau hyperphosphorylation. Silencing RCAN1 prevents Aβ-induced tau hyperphosphorylation.","method":"Primary cortical neuron culture, siRNA knockdown, antioxidant treatment, tau phosphorylation western blot","journal":"Journal of Alzheimer's disease","confidence":"Medium","confidence_rationale":"Tier 2 — functional rescue via RCAN1 silencing with defined pathway placement; single lab","pmids":["21876249"],"is_preprint":false},{"year":2012,"finding":"RCAN1-1L induces mitochondrial autophagy (mitophagy) through adenine nucleotide translocator-dependent mitochondrial permeability transition pore opening, and shifts cellular bioenergetics from aerobic respiration to glycolysis.","method":"Tet-regulated transgene induction, mitochondrial fractionation, mitophagy assays, metabolic assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — regulated transgene with multiple mitochondrial functional readouts; single lab","pmids":["22389495"],"is_preprint":false},{"year":2015,"finding":"Excess RCAN1 impairs neurotrophic support of sympathetic neurons by inhibiting calcineurin-dependent endocytosis of the NGF receptor TrkA. Genetically correcting RCAN1 levels in Down syndrome mice improves NGF-dependent receptor trafficking, neuronal survival, and innervation.","method":"Genetic mouse models (Down syndrome Ts65Dn), live-cell TrkA trafficking assays, genetic rescue of RCAN1 dosage","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — direct receptor trafficking experiment with genetic rescue, clear mechanism defined","pmids":["26658127"],"is_preprint":false},{"year":2013,"finding":"Increased dosage of DSCR1 cooperates with DYRK1A to suppress NFATc transcription factor activity in neural progenitors, causing a delay in neuronal differentiation and alteration of laminar fate in the developing neocortex. Counteracting the dysregulated pathway ameliorates delayed neuronal differentiation in Ts1Cje Down syndrome mice.","method":"In utero electroporation, Ts1Cje mouse model, NFAT reporter assay, genetic epistasis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with in vivo neural progenitor functional readouts","pmids":["24352425"],"is_preprint":false},{"year":2016,"finding":"RCAN1 controls axon outgrowth by modulating growth cone actin dynamics through regulation of cofilin phosphorylation (phospho/dephospho-cofilin). Additionally, DSCR1 mediates BDNF-induced local protein synthesis and growth cone turning.","method":"Live imaging, cofilin phosphorylation assays, DSCR1 KO and overexpression, growth cone turning assay","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct cofilin phosphorylation measurement with functional growth cone assays; single lab","pmids":["27185837"],"is_preprint":false},{"year":2018,"finding":"RCAN1 maintains a more fused mitochondrial network by inhibiting calcineurin-dependent activation of the fission protein DRP1. In RCAN1-depleted cardiomyocytes, increased CN activity promotes DRP1-mediated fragmentation, reduces mitochondrial membrane potential and Ca2+ buffering capacity, and increases susceptibility to ischemia/reperfusion injury.","method":"Cardiomyocyte RCAN1 KO and adenoviral overexpression, mitochondrial morphology imaging, O2 consumption assay, I/R injury model, pharmacological DRP1 and calcineurin inhibition","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — complementary KO and overexpression with pharmacological rescue and multiple functional readouts","pmids":["29362227"],"is_preprint":false},{"year":2012,"finding":"NEDD8 is conjugated to RCAN1 (RCAN1-1S) at lysine residues K96, K104, and K107. Neddylation enhances RCAN1 protein stability by inhibiting proteasomal degradation, increases RCAN1 binding to calcineurin, and potentiates RCAN1 inhibitory activity toward downstream NFAT signaling.","method":"NEDD8 conjugation assay, mutagenesis of lysine residues, co-immunoprecipitation, NFAT reporter assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1-2 — PTM mapped to specific residues with functional calcineurin-binding and NFAT readouts; single lab","pmids":["23118980"],"is_preprint":false},{"year":2008,"finding":"Oxidative stress (H2O2) induces SCFβ-TrCP ubiquitin ligase-mediated ubiquitination of RCAN1, leading to its proteasomal degradation. β-TrCP interacts with RCAN1 in response to H2O2, and siRNA knockdown of β-TrCP abolishes H2O2-induced RCAN1 decrease.","method":"In vitro ubiquitination assay, co-immunoprecipitation, siRNA knockdown, western blotting","journal":"International journal of molecular medicine","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro ubiquitination assay combined with siRNA rescue; single lab","pmids":["18575781"],"is_preprint":false},{"year":2008,"finding":"CREB activates proteasomal degradation of RCAN1/DSCR1 through the ubiquitin-proteasome pathway. CREB enhances ubiquitination and increases the turnover rate of RCAN1, and this requires CREB's transcriptional activation domain.","method":"Proteasome inhibitor experiments, ubiquitination assay, CREB overexpression and dominant-negative constructs, pulse-chase analysis","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — defined E3 pathway with multiple supporting assays; single lab","pmids":["18485898"],"is_preprint":false},{"year":2005,"finding":"Raf-1 is a binding partner of DSCR1. Two Raf-1 binding regions exist in DSCR1: one in the N-terminus and one in the C-terminus. Calpain cleavage of DSCR1 generates fragments with differential binding affinity to Raf-1 versus calcineurin.","method":"GST pulldown, co-immunoprecipitation, calpain cleavage assay","journal":"Archives of biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 — single pulldown/Co-IP without functional consequence defined; single lab","pmids":["15935327"],"is_preprint":false},{"year":2002,"finding":"DSCR1 protein (calcipressin 1) protects cells against acute oxidative stress and calcium stress. Resistance to these stresses increased as a function of DSCR1/calcipressin 1 expression and decreased when gene/protein expression diminished, consistent with calcineurin inhibition being the protective mechanism.","method":"Stable transfection, tet-off regulated transgene expression, antisense oligonucleotides, cell viability assays after H2O2 and calcium ionophore A23187 challenge","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — complementary gain- and loss-of-function approaches with defined stress phenotype; single lab","pmids":["12039863"],"is_preprint":false},{"year":2003,"finding":"Oxidative stress causes rapid hyperphosphorylation of DSCR1 protein. Phosphorylation of serines in the calcineurin-interacting conserved region of DSCR1 attenuates its inhibition of calcineurin, suggesting phosphorylation modulates calcineurin inhibitory activity.","method":"H2O2 treatment of cells, kinase inhibitor studies, in vitro calcineurin inhibition assay with phosphorylated peptides","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro peptide/calcineurin assay combined with cell-based phosphorylation studies; single lab","pmids":["12927602"],"is_preprint":false},{"year":2002,"finding":"DSCR1 subcellular localization is preferentially nuclear, independent of isoform or cell line. A segment in the C-terminus is important for nuclear localization, and serine/threonine residues in this region regulate nuclear targeting, suggesting phosphorylation-dependent regulation of DSCR1 localization.","method":"GFP fusion constructs in multiple cell lines, deletion mutagenesis, site-directed mutagenesis","journal":"BMC cell biology","confidence":"Medium","confidence_rationale":"Tier 2 — direct imaging with systematic mutagenesis in multiple cell lines; single lab","pmids":["12225619"],"is_preprint":false},{"year":2011,"finding":"RCAN1 functions as an inhibitor of calcineurin when its levels are low and as a facilitator when levels are high. Nuclear export of GSK3β, promoted by PI3K signaling, switches on the facilitative role of RCAN1 through sequential phosphorylation, forming a hidden incoherent regulatory switch.","method":"Single-cell live imaging, mathematical modelling, pharmacological PI3K inhibition, NFAT localization assays","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 — systems approach combining single-cell experiment with computational modelling; single lab","pmids":["21172821"],"is_preprint":false},{"year":2019,"finding":"DSCR1 binds to TET1 introns to regulate splicing of TET1, modulating TET1 protein level. TET1 in turn controls demethylation of the miR-124 promoter to modulate miR-124 expression, thereby regulating adult hippocampal neurogenesis. Correcting TET1 levels in DSCR1 KO mice prevents defective adult neurogenesis.","method":"Co-IP, RNA splicing analysis, DSCR1 KO mice, TET1 level correction, adult neurogenesis assays","journal":"The EMBO journal","confidence":"Medium","confidence_rationale":"Tier 2 — novel mechanism (splicing regulation) with genetic rescue; single lab","pmids":["31304631"],"is_preprint":false},{"year":2010,"finding":"RCAN1.4 expression is induced by VEGFR-2 activation in a Ca2+ and PKC-delta dependent manner. siRNA silencing of RCAN1.4 results in increased NFAT-regulated gene expression, decreased cellular migration, and disrupted tubular morphogenesis.","method":"PKC inhibitors, siRNA knockdown of PKC-delta, RCAN1.4 siRNA, endothelial cell migration and tube formation assays, NFAT reporter","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological and siRNA epistasis with defined signaling pathway and cellular phenotype; single lab","pmids":["20625401"],"is_preprint":false},{"year":2017,"finding":"RCAN1.4 regulates agonist-stimulated VEGFR-2 internalisation and establishment of endothelial cell polarity. siRNA silencing of RCAN1 inhibits VEGF-mediated cytoskeletal reorganisation and directed cell migration. Morpholino silencing of zebrafish RCAN1.4 orthologue disrupts vascular development.","method":"siRNA knockdown, VEGFR-2 internalization assay, cell polarity assay, migration/sprouting assays, zebrafish morpholino knockdown","journal":"Angiogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — multiple assays in human cells plus zebrafish validation; single lab","pmids":["28271280"],"is_preprint":false},{"year":2011,"finding":"RCAN1 activates CREB phosphorylation and cAMP response element-mediated gene transcription. This CREB activation is dependent on RCAN1's ability to inhibit calcineurin activity.","method":"RCAN1 overexpression, CREB phosphorylation western blot, CRE-luciferase reporter assay, calcineurin inhibition","journal":"The Journal of biological chemistry","confidence":"Low","confidence_rationale":"Tier 3 — overexpression only with reporter assay, mechanism inferred from calcineurin inhibition; single lab","pmids":["21890628"],"is_preprint":false},{"year":2009,"finding":"RCAN1 (Rcan1) negatively regulates FcεRI-mediated mast cell activation by inhibiting calcineurin activity, thereby suppressing NFAT and NF-κB activation and reducing cytokine production and degranulation. Rcan1 expression in mast cells is controlled by the transcription factor Egr1 through a functional Egr1 binding site in the Rcan1 promoter.","method":"Rcan1 KO mice, mast cell calcineurin activity assay, NFAT/NF-κB reporter assays, Egr1 promoter binding (EMSA/ChIP), passive cutaneous anaphylaxis","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with multiple in vivo and in vitro functional readouts and defined transcriptional mechanism","pmids":["19124655"],"is_preprint":false},{"year":2015,"finding":"RCAN1 contributes to circadian rhythmicity in cardiac protection from ischemia/reperfusion. RCAN1 KO mice lose the time-of-day difference in infarct size, while calcineurin inhibition by FK506 restores protection in PM-operated animals, placing RCAN1-calcineurin signaling as a mediator of circadian cardiac protection.","method":"RCAN1 KO and transgenic mice, timed I/R surgery, FK506 pharmacological rescue, echocardiography","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple genetic models with pharmacological rescue; single lab","pmids":["24838101"],"is_preprint":false},{"year":2013,"finding":"RCAN1 regulates CD36 expression in macrophages and its genetic inactivation reduces atherosclerosis in Apoe-/- mice. This is mechanistically linked to diminished oxLDL uptake, resistance to oxLDL-mediated inhibition of macrophage migration, and increased anti-inflammatory marker expression. Haematopoietic Rcan1 is the key contributor, demonstrated by bone marrow transplantation.","method":"Rcan1/Apoe double KO mice, bone marrow transplantation, macrophage oxLDL uptake, CD36 expression analysis","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with bone marrow transplant to identify cellular source; single lab","pmids":["24127415"],"is_preprint":false},{"year":2015,"finding":"RCAN1 overexpression in mice promotes age-dependent tau pathology and dysregulation of DRP1 activity associated with mitochondrial dysfunction and oxidative stress, identifying RCAN1 as an upstream regulator of DRP1-mediated mitochondrial fission.","method":"Brain-specific RCAN1.1S transgenic mice, tau phosphorylation assay, DRP1 activity assay, memory tests, mitochondrial function assays","journal":"Acta neuropathologica","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic overexpression with defined biochemical and behavioral readouts; single lab","pmids":["26497675"],"is_preprint":false},{"year":2017,"finding":"LRRK2 phosphorylates RCAN1-1S, and during IL-1β treatment this promotes formation of protein complexes including Tollip-RCAN1, decreases Tollip-IRAK1 binding, increases IRAK1-TRAF6 complex formation, and enhances TAK1 activity and NF-κB transcriptional activity.","method":"In vitro kinase assay, co-immunoprecipitation, LRRK2 overexpression, NF-κB reporter assay","journal":"Frontiers in cellular neuroscience","confidence":"Low","confidence_rationale":"Tier 3 — single lab, kinase assay without mutagenesis confirmation of phosphorylation sites","pmids":["28553204"],"is_preprint":false},{"year":2015,"finding":"RCAN1 interacts with IκBα and affects phosphorylation of IκBα at tyrosine 42, thereby inhibiting NF-κB signaling. The N-terminal 1-103aa of RCAN1 is sufficient for NF-κB inhibition.","method":"Co-immunoprecipitation, IκBα tyrosine phosphorylation assay, RCAN1 domain mapping, NF-κB reporter, lymphoma xenograft","journal":"Cell death & disease","confidence":"Low","confidence_rationale":"Tier 3 — Co-IP with limited mechanistic follow-up; single lab","pmids":["26492364"],"is_preprint":false},{"year":2010,"finding":"C/EBPβ cooperates with NFAT to regulate RCAN1-4 expression. C/EBPβ binds multiple conserved sites in the RCAN1-4 proximal promoter, directly interacts with NFAT, and is required for maximal calcineurin-induced RCAN1-4 expression. C/EBPβ can also activate RCAN1-4 expression independently of calcineurin.","method":"EMSA, ChIP, co-immunoprecipitation of C/EBPβ and NFAT, luciferase reporter assay, C/EBPβ siRNA depletion","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (EMSA, ChIP, Co-IP, reporter, siRNA) demonstrating direct protein-DNA and protein-protein interactions","pmids":["20371871"],"is_preprint":false},{"year":2011,"finding":"In Drosophila, sarah (sra, the RCAN1 ortholog) is required for normal sleep. sra sleep defects are suppressed by calcineurin (CN) mutations, placing sra and CN in a common pathway regulating sleep. Pan-neural expression of sra rescues the behavioral phenotype, indicating neuronal sra function is required.","method":"Drosophila sra mutant sleep analysis, CN subunit KO, genetic epistasis (sra;CN double mutants), pan-neural rescue","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis in Drosophila ortholog with multiple CN subunit KOs; relevant conserved function","pmids":["21900555"],"is_preprint":false},{"year":2019,"finding":"RCAN1.4 expression is suppressed by DNA methylation mediated by DNMT1 and DNMT3b in liver fibrosis. RCAN1.4 overexpression alleviates liver fibrosis through inhibition of CaN/NFAT3 signaling, while RCAN1.4 knockdown exacerbates TGF-β1-induced fibrosis.","method":"Bisulfite sequencing, ChIP assay for DNMT1/DNMT3b, rAAV8-RCAN1.4 overexpression in mouse liver, NFAT3 reporter","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-confirmed epigenetic mechanism with in vivo rescue experiment","pmids":["31285763"],"is_preprint":false},{"year":2004,"finding":"DSCR1 expression stimulates SOD1 (Cu,Zn superoxide dismutase) gene expression and increases SOD1 enzyme activity in PC12 cells, identified through microarray analysis of DSCR1-regulated mRNAs.","method":"Tet-off regulated DSCR1 transgene in PC12 cells, microarray, SOD1 enzyme activity assay","journal":"FASEB journal","confidence":"Low","confidence_rationale":"Tier 3 — single lab, microarray identification without mechanistic link between RCAN1 and SOD1","pmids":["14718387"],"is_preprint":false}],"current_model":"RCAN1 is an endogenous inhibitor of the Ca2+/calmodulin-dependent phosphatase calcineurin, binding directly to its linker region to block NFAT dephosphorylation and nuclear translocation; its activity is bidirectionally regulated by phosphorylation (by DYRK1A at Thr192/Ser112, by TAK1 at Ser94/Ser136, and priming by GSK3β at Ser108), by post-translational modifications including neddylation (which stabilizes RCAN1 and potentiates calcineurin inhibition) and SCFβ-TrCP-mediated ubiquitination (which promotes proteasomal degradation), and by chaperone-mediated autophagy; at the cellular level RCAN1 maintains mitochondrial fusion by suppressing calcineurin-dependent DRP1 activation, regulates vesicle exocytosis and fusion pore kinetics, controls axon outgrowth through cofilin-dependent actin dynamics and local protein synthesis, modulates TrkA endocytosis to support neurotrophin signaling, regulates adult hippocampal neurogenesis through TET1 splicing and miR-124 demethylation, and acts as a dose-dependent switch in calcineurin-NFAT signaling (inhibitor at low levels, facilitator at high levels via GSK3β nuclear export), with cooperative action alongside DYRK1A to suppress NFATc activity underpinning multiple Down syndrome-associated developmental and neurodegenerative phenotypes."},"narrative":{"teleology":[{"year":2000,"claim":"Identification of RCAN1 as a direct physical inhibitor of calcineurin resolved how an endogenous protein modulates calcineurin-NFAT signaling, establishing the core molecular function of the gene.","evidence":"Co-immunoprecipitation, domain mapping to calcineurin A linker region, and NFAT nuclear translocation/transcription assays in mammalian cells","pmids":["10861295"],"confidence":"High","gaps":["Structural basis of the RCAN1-calcineurin interface not resolved","Endogenous stoichiometry and tissue-specific regulation unknown"]},{"year":2002,"claim":"Demonstration that RCAN1 protects cells from oxidative and calcium stress established a cytoprotective role consistent with calcineurin inhibition, and that RCAN1 localizes preferentially to the nucleus suggested compartmentalized regulation.","evidence":"Tet-off regulated transgene and antisense knockdown with stress challenge in cell lines; GFP-fusion imaging with deletion mutagenesis","pmids":["12039863","12225619"],"confidence":"Medium","gaps":["Nuclear versus cytoplasmic functional partitioning not mechanistically dissected","Phosphorylation sites controlling localization not identified"]},{"year":2004,"claim":"Discovery that RCAN1 is itself a VEGF/calcineurin target gene revealed a negative feedback loop in endothelial calcineurin-NFAT signaling, explaining how inflammatory gene expression (tissue factor, E-selectin, Cox-2) is self-limited.","evidence":"siRNA knockdown of RCAN1 in endothelial cells with NFAT reporter and genome-wide expression analysis","pmids":["15016650"],"confidence":"High","gaps":["Identity of the calcineurin-responsive elements in the RCAN1 promoter only partially mapped","Contribution of individual RCAN1 isoforms to feedback not resolved"]},{"year":2005,"claim":"Mapping the minimal calcineurin-inhibitory peptide within RCAN1 demonstrated that a short competitive fragment suffices for full enzymatic inhibition, defining the pharmacologically relevant domain.","evidence":"In vitro and in vivo calcineurin phosphatase activity assays with synthetic peptide fragments","pmids":["16131541"],"confidence":"High","gaps":["Atomic-resolution structure of peptide-calcineurin complex not determined"]},{"year":2006,"claim":"The demonstration that 1.5-fold increases in RCAN1 and DYRK1A synergistically suppress NFAT nuclear occupancy provided a molecular explanation for Down syndrome phenotypes caused by chromosome 21 trisomy.","evidence":"Mathematical modelling combined with genetic mouse models (calcineurin/Nfatc KO, Dscr1/Dyrk1a transgenic overexpression)","pmids":["16554754"],"confidence":"High","gaps":["Quantitative contribution of each gene to individual DS phenotypes not separated","Whether other chromosome 21 genes modulate this circuit in vivo not tested"]},{"year":2008,"claim":"Multiple discoveries in 2008 expanded RCAN1's regulatory landscape: isoform-specific roles in angiogenesis (Ex4 inhibits, Ex1 promotes), ATF6-mediated ER stress induction linking unfolded protein response to calcineurin, SCFβ-TrCP-mediated ubiquitin-proteasomal degradation under oxidative stress, and regulation of vesicle exocytosis kinetics independent of acute calcineurin inhibition.","evidence":"RCAN1 KO mice with tumor xenograft and CsA rescue; ATF6 transgenic mice with calcineurin activity assay; in vitro ubiquitination assay with β-TrCP siRNA; carbon-fiber amperometry in chromaffin cells from KO and overexpressing mice","pmids":["18455125","18319259","18575781","18180251"],"confidence":"High","gaps":["Mechanism by which RCAN1 regulates fusion pore kinetics independent of calcineurin not identified","Whether ATF6-RCAN1 axis operates beyond cardiomyocytes unknown","Phosphodegron recognized by β-TrCP not mapped"]},{"year":2009,"claim":"TAK1 phosphorylation of RCAN1 at Ser94/Ser136 was shown to convert RCAN1 from a calcineurin inhibitor to a facilitator, revealing a phosphorylation-dependent functional switch that promotes cardiomyocyte hypertrophy and mast cell activation, while simultaneous studies confirmed RCAN1 degradation by chaperone-mediated autophagy.","evidence":"Yeast two-hybrid identification of TAB2, Co-IP of TAK1-TAB1-RCAN1-calcineurin complex, in vitro kinase assay with mutagenesis; Rcan1 KO mast cells with calcineurin activity/NFAT/NF-κB reporters; CMA motif identification with lysosomal/macroautophagy inhibitors","pmids":["19136967","19124655","19509306"],"confidence":"High","gaps":["Structural basis for how phosphorylation switches RCAN1 from inhibitor to facilitator unknown","Whether CMA and proteasomal degradation are independently regulated not established"]},{"year":2011,"claim":"DYRK1A was shown to phosphorylate RCAN1 at Ser112 (priming for GSK3β at Ser108) and Thr192 (enhancing calcineurin binding), while systems-level modelling revealed that RCAN1 functions as a concentration-dependent switch—inhibitor at low and facilitator at high levels—governed by PI3K-driven GSK3β nuclear export.","evidence":"In vitro kinase assay with site-directed mutagenesis and NFAT reporter; single-cell live imaging with mathematical modelling and PI3K pharmacological inhibition","pmids":["21965663","21172821"],"confidence":"High","gaps":["In vivo validation of the dual-switch model in specific tissues not performed","Whether additional kinases contribute to the switch not explored"]},{"year":2012,"claim":"Neddylation of RCAN1 at K96/K104/K107 was found to stabilize the protein and potentiate calcineurin inhibition, while RCAN1 was linked to Aβ-induced tau hyperphosphorylation through calcineurin inhibition and GSK3β upregulation, and shown to interact with FMRP to regulate dendritic spine morphogenesis and local protein synthesis.","evidence":"NEDD8 conjugation assay with lysine mutagenesis and NFAT reporter; RCAN1 siRNA rescue of Aβ-induced tau phosphorylation in primary cortical neurons; Co-IP of RCAN1-FMRP with dendritic spine imaging and genetic epistasis","pmids":["23118980","21876249","22863780"],"confidence":"Medium","gaps":["E3 ligase responsible for RCAN1 neddylation not identified","Whether FMRP interaction is calcineurin-dependent not tested","Direct versus indirect mechanism of GSK3β upregulation by RCAN1 unclear"]},{"year":2013,"claim":"RCAN1-DYRK1A cooperative suppression of NFAT was demonstrated to delay neuronal differentiation and alter cortical laminar fate in vivo, directly linking the dosage-sensitive calcineurin-NFAT circuit to Down syndrome neurodevelopmental defects.","evidence":"In utero electroporation in Ts1Cje Down syndrome mice with NFAT reporter assay and genetic epistasis","pmids":["24352425"],"confidence":"High","gaps":["Whether postnatal correction of the RCAN1-DYRK1A imbalance rescues cortical deficits not tested"]},{"year":2015,"claim":"RCAN1 excess was shown to impair NGF-dependent TrkA endocytosis, compromising sympathetic neuron survival and innervation in a Down syndrome mouse model, establishing receptor trafficking as a calcineurin-dependent RCAN1 function.","evidence":"Live-cell TrkA trafficking assays in Ts65Dn Down syndrome mouse sympathetic neurons with genetic correction of RCAN1 dosage","pmids":["26658127"],"confidence":"High","gaps":["Whether other receptor tyrosine kinases are similarly regulated by RCAN1-calcineurin not tested"]},{"year":2016,"claim":"RCAN1 was found to control axon outgrowth by modulating cofilin phosphorylation and actin dynamics in growth cones, and to mediate BDNF-induced local protein synthesis and growth cone turning, defining a non-transcriptional cytoskeletal role.","evidence":"Live imaging of growth cones, cofilin phosphorylation assays, RCAN1 KO and overexpression, growth cone turning assay","pmids":["27185837"],"confidence":"Medium","gaps":["Whether cofilin regulation is calcineurin-dependent or through a separate pathway not fully resolved","Mechanism of RCAN1-dependent local translation not defined"]},{"year":2018,"claim":"RCAN1 was established as a maintainer of mitochondrial fusion in cardiomyocytes by inhibiting calcineurin-dependent DRP1 dephosphorylation and activation, with RCAN1 loss leading to mitochondrial fragmentation, impaired Ca2+ buffering, and increased ischemia/reperfusion injury.","evidence":"Cardiomyocyte RCAN1 KO and adenoviral overexpression with pharmacological DRP1/calcineurin inhibition, mitochondrial morphology imaging, and I/R injury model","pmids":["29362227"],"confidence":"High","gaps":["Whether RCAN1-DRP1 axis operates in non-cardiac tissues with high mitochondrial demand not tested","Specific DRP1 phosphorylation site regulated by RCAN1-calcineurin not mapped"]},{"year":2019,"claim":"A calcineurin-independent function was uncovered: RCAN1 binds TET1 introns to regulate TET1 splicing, controlling TET1 protein levels and downstream miR-124 promoter demethylation, thereby regulating adult hippocampal neurogenesis.","evidence":"Co-IP and RNA splicing analysis in RCAN1 KO mice, TET1 level correction rescuing adult neurogenesis defects","pmids":["31304631"],"confidence":"Medium","gaps":["Whether RCAN1-TET1 splicing regulation is direct RNA binding or mediated through a spliceosome component not determined","Generality of RCAN1 splicing regulation beyond TET1 unknown"]},{"year":null,"claim":"Key unresolved questions include the atomic-resolution structure of the RCAN1-calcineurin complex, the full spectrum of calcineurin-independent RCAN1 functions, how isoform-specific and tissue-specific RCAN1 activities are coordinated, and whether therapeutic modulation of RCAN1 can ameliorate Down syndrome or neurodegeneration phenotypes.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structural model of the RCAN1-calcineurin complex exists","Calcineurin-independent functions (FMRP, TET1 splicing, vesicle exocytosis) lack mechanistic integration","Isoform-specific roles (Ex1 vs Ex4) in angiogenesis and neurodegeneration not fully dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,4,5,6,21,28]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[4,13]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[27]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,4]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,4,5,28,33]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[33,35]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,18]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[12]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[20,36]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[16]}],"complexes":["TAK1-TAB1-TAB2-RCAN1-calcineurin signaling complex"],"partners":["PPP3CA","DYRK1A","TAB2","TAK1","FMRP","NEDD8","BTRC","TET1"],"other_free_text":[]},"mechanistic_narrative":"RCAN1 is an endogenous regulator of the calcium/calmodulin-dependent phosphatase calcineurin, functioning as a central modulator of calcineurin-NFAT signaling across cardiovascular, immune, and neural systems. RCAN1 binds the linker region of the calcineurin A catalytic subunit via a minimal inhibitory peptide domain, blocking NFAT dephosphorylation and nuclear translocation; this inhibitory activity is enhanced by DYRK1A-mediated phosphorylation at Thr192 and by neddylation at K96/K104/K107, while TAK1 phosphorylation at Ser94/Ser136 converts RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signaling, and SCFβ-TrCP-mediated ubiquitination targets it for proteasomal degradation [PMID:10861295, PMID:21965663, PMID:23118980, PMID:19136967, PMID:18575781]. Beyond calcineurin-NFAT regulation, RCAN1 maintains mitochondrial fusion by suppressing calcineurin-dependent DRP1 activation, controls axon outgrowth through cofilin-dependent actin dynamics, regulates TrkA endocytosis for neurotrophin signaling, modulates vesicle exocytosis kinetics, and regulates adult hippocampal neurogenesis through TET1 splicing [PMID:29362227, PMID:27185837, PMID:26658127, PMID:18180251, PMID:31304631]. Cooperative overexpression of RCAN1 with DYRK1A—both encoded on chromosome 21—destabilizes NFAT signaling and underlies multiple Down syndrome-associated phenotypes including impaired neuronal differentiation, defective angiogenesis, and neurodegeneration [PMID:16554754, PMID:24352425, PMID:19458618]."},"prefetch_data":{"uniprot":{"accession":"P53805","full_name":"Calcipressin-1","aliases":["Adapt78","Down syndrome critical region protein 1","Myocyte-enriched calcineurin-interacting protein 1","MCIP1","Regulator of calcineurin 1"],"length_aa":252,"mass_kda":28.1,"function":"Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A (PubMed:12809556). Could play a role during central nervous system development (By similarity)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P53805/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RCAN1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM2","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/RCAN1","total_profiled":1310},"omim":[{"mim_id":"615321","title":"CHLORIDE INTRACELLULAR CHANNEL 6; CLIC6","url":"https://www.omim.org/entry/615321"},{"mim_id":"605860","title":"RCAN FAMILY MEMBER 3; RCAN3","url":"https://www.omim.org/entry/605860"},{"mim_id":"605602","title":"MYOZENIN 2; MYOZ2","url":"https://www.omim.org/entry/605602"},{"mim_id":"602917","title":"REGULATOR OF CALCINEURIN 1; RCAN1","url":"https://www.omim.org/entry/602917"},{"mim_id":"600855","title":"DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1A; DYRK1A","url":"https://www.omim.org/entry/600855"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":239.5},{"tissue":"parathyroid gland","ntpm":426.0}],"url":"https://www.proteinatlas.org/search/RCAN1"},"hgnc":{"alias_symbol":[],"prev_symbol":["DSCR1"]},"alphafold":{"accession":"P53805","domains":[{"cath_id":"3.30.70.330","chopping":"74-135","consensus_level":"high","plddt":95.199,"start":74,"end":135}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P53805","model_url":"https://alphafold.ebi.ac.uk/files/AF-P53805-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P53805-F1-predicted_aligned_error_v6.png","plddt_mean":73.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RCAN1","jax_strain_url":"https://www.jax.org/strain/search?query=RCAN1"},"sequence":{"accession":"P53805","fasta_url":"https://rest.uniprot.org/uniprotkb/P53805.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P53805/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P53805"}},"corpus_meta":[{"pmid":"16554754","id":"PMC_16554754","title":"NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16554754","citation_count":530,"is_preprint":false},{"pmid":"10861295","id":"PMC_10861295","title":"DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10861295","citation_count":395,"is_preprint":false},{"pmid":"19458618","id":"PMC_19458618","title":"Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19458618","citation_count":286,"is_preprint":false},{"pmid":"11483593","id":"PMC_11483593","title":"Chronic overexpression of the calcineurin inhibitory gene DSCR1 (Adapt78) is associated with Alzheimer's disease.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11483593","citation_count":177,"is_preprint":false},{"pmid":"9325060","id":"PMC_9325060","title":"Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9325060","citation_count":165,"is_preprint":false},{"pmid":"16939415","id":"PMC_16939415","title":"Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16939415","citation_count":148,"is_preprint":false},{"pmid":"15016650","id":"PMC_15016650","title":"Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells.","date":"2004","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15016650","citation_count":139,"is_preprint":false},{"pmid":"19136967","id":"PMC_19136967","title":"Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point.","date":"2009","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19136967","citation_count":112,"is_preprint":false},{"pmid":"12039863","id":"PMC_12039863","title":"The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress.","date":"2002","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/12039863","citation_count":111,"is_preprint":false},{"pmid":"18455125","id":"PMC_18455125","title":"Targeted deletion of the calcineurin inhibitor DSCR1 suppresses tumor growth.","date":"2008","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/18455125","citation_count":110,"is_preprint":false},{"pmid":"21876249","id":"PMC_21876249","title":"Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.","date":"2011","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/21876249","citation_count":109,"is_preprint":false},{"pmid":"27872486","id":"PMC_27872486","title":"Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.","date":"2016","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27872486","citation_count":109,"is_preprint":false},{"pmid":"19509306","id":"PMC_19509306","title":"Degradation of regulator of calcineurin 1 (RCAN1) is mediated by both chaperone-mediated autophagy and ubiquitin proteasome pathways.","date":"2009","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/19509306","citation_count":101,"is_preprint":false},{"pmid":"16131541","id":"PMC_16131541","title":"Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16131541","citation_count":97,"is_preprint":false},{"pmid":"21216952","id":"PMC_21216952","title":"Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21216952","citation_count":95,"is_preprint":false},{"pmid":"32004570","id":"PMC_32004570","title":"Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.","date":"2020","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/32004570","citation_count":90,"is_preprint":false},{"pmid":"18045910","id":"PMC_18045910","title":"The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18045910","citation_count":90,"is_preprint":false},{"pmid":"16231093","id":"PMC_16231093","title":"Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease.","date":"2005","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/16231093","citation_count":90,"is_preprint":false},{"pmid":"18319259","id":"PMC_18319259","title":"Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18319259","citation_count":87,"is_preprint":false},{"pmid":"17341486","id":"PMC_17341486","title":"RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17341486","citation_count":74,"is_preprint":false},{"pmid":"22511596","id":"PMC_22511596","title":"Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22511596","citation_count":69,"is_preprint":false},{"pmid":"18180251","id":"PMC_18180251","title":"DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease.","date":"2008","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18180251","citation_count":69,"is_preprint":false},{"pmid":"21965663","id":"PMC_21965663","title":"Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21965663","citation_count":67,"is_preprint":false},{"pmid":"10756093","id":"PMC_10756093","title":"A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2).","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/10756093","citation_count":67,"is_preprint":false},{"pmid":"19192387","id":"PMC_19192387","title":"Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1.","date":"2009","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/19192387","citation_count":66,"is_preprint":false},{"pmid":"17331188","id":"PMC_17331188","title":"RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.","date":"2007","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/17331188","citation_count":65,"is_preprint":false},{"pmid":"12927602","id":"PMC_12927602","title":"Oxidative and calcium stress regulate DSCR1 (Adapt78/MCIP1) protein.","date":"2003","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12927602","citation_count":63,"is_preprint":false},{"pmid":"23038757","id":"PMC_23038757","title":"Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis.","date":"2012","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/23038757","citation_count":63,"is_preprint":false},{"pmid":"22389495","id":"PMC_22389495","title":"Chronic expression of RCAN1-1L protein induces mitochondrial autophagy and metabolic shift from oxidative phosphorylation to glycolysis in neuronal cells.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22389495","citation_count":59,"is_preprint":false},{"pmid":"26497675","id":"PMC_26497675","title":"RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.","date":"2015","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/26497675","citation_count":59,"is_preprint":false},{"pmid":"28271280","id":"PMC_28271280","title":"RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells.","date":"2017","source":"Angiogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28271280","citation_count":57,"is_preprint":false},{"pmid":"11231093","id":"PMC_11231093","title":"Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11231093","citation_count":57,"is_preprint":false},{"pmid":"32771023","id":"PMC_32771023","title":"Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.","date":"2020","source":"Molecular cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32771023","citation_count":56,"is_preprint":false},{"pmid":"16442855","id":"PMC_16442855","title":"Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1.","date":"2006","source":"Ageing research reviews","url":"https://pubmed.ncbi.nlm.nih.gov/16442855","citation_count":56,"is_preprint":false},{"pmid":"18293408","id":"PMC_18293408","title":"Calcium/calcineurin signaling in primary cortical astrocyte cultures: Rcan1-4 and cyclooxygenase-2 as NFAT target genes.","date":"2008","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/18293408","citation_count":55,"is_preprint":false},{"pmid":"16649988","id":"PMC_16649988","title":"RCAN1 (DSCR1 or Adapt78) stimulates expression of GSK-3beta.","date":"2006","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/16649988","citation_count":53,"is_preprint":false},{"pmid":"22397398","id":"PMC_22397398","title":"Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury.","date":"2012","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22397398","citation_count":51,"is_preprint":false},{"pmid":"29362227","id":"PMC_29362227","title":"Down Syndrome Critical Region 1 Gene, Rcan1, Helps Maintain a More Fused Mitochondrial Network.","date":"2018","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/29362227","citation_count":50,"is_preprint":false},{"pmid":"23028325","id":"PMC_23028325","title":"Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCγ1 and activating NFAT1-dependent RCAN1 expression.","date":"2012","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/23028325","citation_count":50,"is_preprint":false},{"pmid":"28289712","id":"PMC_28289712","title":"RCAN1-4 is a thyroid cancer growth and metastasis suppressor.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28289712","citation_count":49,"is_preprint":false},{"pmid":"31285763","id":"PMC_31285763","title":"Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31285763","citation_count":47,"is_preprint":false},{"pmid":"22863780","id":"PMC_22863780","title":"DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22863780","citation_count":45,"is_preprint":false},{"pmid":"21900555","id":"PMC_21900555","title":"Calcineurin and its regulator sra/DSCR1 are essential for sleep in Drosophila.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21900555","citation_count":44,"is_preprint":false},{"pmid":"26658127","id":"PMC_26658127","title":"RCAN1 links impaired neurotrophin trafficking to aberrant development of the sympathetic nervous system in Down syndrome.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26658127","citation_count":43,"is_preprint":false},{"pmid":"24352425","id":"PMC_24352425","title":"Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/24352425","citation_count":42,"is_preprint":false},{"pmid":"27195491","id":"PMC_27195491","title":"A Syntenic Cross Species Aneuploidy Genetic Screen Links RCAN1 Expression to β-Cell Mitochondrial Dysfunction in Type 2 Diabetes.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27195491","citation_count":42,"is_preprint":false},{"pmid":"21172821","id":"PMC_21172821","title":"A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network.","date":"2011","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/21172821","citation_count":41,"is_preprint":false},{"pmid":"24751678","id":"PMC_24751678","title":"RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24751678","citation_count":41,"is_preprint":false},{"pmid":"15009650","id":"PMC_15009650","title":"Aggregate formation and synaptic abnormality induced by DSCR1.","date":"2004","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15009650","citation_count":40,"is_preprint":false},{"pmid":"20625401","id":"PMC_20625401","title":"VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20625401","citation_count":40,"is_preprint":false},{"pmid":"24838101","id":"PMC_24838101","title":"Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion.","date":"2014","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/24838101","citation_count":39,"is_preprint":false},{"pmid":"21680892","id":"PMC_21680892","title":"Do RCAN1 proteins link chronic stress with neurodegeneration?","date":"2011","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/21680892","citation_count":39,"is_preprint":false},{"pmid":"23011918","id":"PMC_23011918","title":"Increased expression of the glucose-responsive gene, RCAN1, causes hypoinsulinemia, β-cell dysfunction, and diabetes.","date":"2012","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/23011918","citation_count":39,"is_preprint":false},{"pmid":"24127415","id":"PMC_24127415","title":"A major role for RCAN1 in atherosclerosis progression.","date":"2013","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24127415","citation_count":38,"is_preprint":false},{"pmid":"24505143","id":"PMC_24505143","title":"Calcineurin-NFAT activation and DSCR-1 auto-inhibitory loop: how is homoeostasis regulated?","date":"2014","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24505143","citation_count":36,"is_preprint":false},{"pmid":"19270310","id":"PMC_19270310","title":"Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19270310","citation_count":36,"is_preprint":false},{"pmid":"30139658","id":"PMC_30139658","title":"RCAN1 is a marker of oxidative stress, induced in acute pancreatitis.","date":"2018","source":"Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/30139658","citation_count":36,"is_preprint":false},{"pmid":"23369757","id":"PMC_23369757","title":"Chronic high levels of the RCAN1-1 protein may promote neurodegeneration and Alzheimer disease.","date":"2013","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23369757","citation_count":35,"is_preprint":false},{"pmid":"31880863","id":"PMC_31880863","title":"Genome-wide mRNA profiling identifies RCAN1 and GADD45A as regulators of the transitional switch from survival to apoptosis during ER stress.","date":"2020","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/31880863","citation_count":35,"is_preprint":false},{"pmid":"21364922","id":"PMC_21364922","title":"Behavioral characterization of a mouse model overexpressing DSCR1/ RCAN1.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21364922","citation_count":34,"is_preprint":false},{"pmid":"24752590","id":"PMC_24752590","title":"Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.","date":"2014","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24752590","citation_count":32,"is_preprint":false},{"pmid":"25377251","id":"PMC_25377251","title":"Overexpression of Rcan1-1L inhibits hypoxia-induced cell apoptosis through induction of mitophagy.","date":"2014","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/25377251","citation_count":32,"is_preprint":false},{"pmid":"20371871","id":"PMC_20371871","title":"The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20371871","citation_count":32,"is_preprint":false},{"pmid":"24086147","id":"PMC_24086147","title":"Nebula/DSCR1 upregulation delays neurodegeneration and protects against APP-induced axonal transport defects by restoring calcineurin and GSK-3β signaling.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24086147","citation_count":31,"is_preprint":false},{"pmid":"14718387","id":"PMC_14718387","title":"DSCR1(Adapt78) modulates expression of SOD1.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/14718387","citation_count":30,"is_preprint":false},{"pmid":"29094385","id":"PMC_29094385","title":"The neuronal and endocrine roles of RCAN1 in health and disease.","date":"2017","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29094385","citation_count":29,"is_preprint":false},{"pmid":"26492364","id":"PMC_26492364","title":"The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice.","date":"2015","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/26492364","citation_count":29,"is_preprint":false},{"pmid":"19926569","id":"PMC_19926569","title":"Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.","date":"2009","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19926569","citation_count":29,"is_preprint":false},{"pmid":"30366682","id":"PMC_30366682","title":"Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury.","date":"2018","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/30366682","citation_count":28,"is_preprint":false},{"pmid":"18485347","id":"PMC_18485347","title":"Upregulation of DSCR1 (RCAN1 or Adapt78) in the peri-infarct cortex after experimental stroke.","date":"2008","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18485347","citation_count":28,"is_preprint":false},{"pmid":"18641051","id":"PMC_18641051","title":"c-Jun inhibits thapsigargin-induced ER stress through up-regulation of DSCR1/Adapt78.","date":"2008","source":"Experimental biology and medicine (Maywood, N.J.)","url":"https://pubmed.ncbi.nlm.nih.gov/18641051","citation_count":27,"is_preprint":false},{"pmid":"15935327","id":"PMC_15935327","title":"Raf-1 is a binding partner of DSCR1.","date":"2005","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/15935327","citation_count":26,"is_preprint":false},{"pmid":"27185837","id":"PMC_27185837","title":"DSCR1 is required for both axonal growth cone extension and steering.","date":"2016","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27185837","citation_count":26,"is_preprint":false},{"pmid":"25009690","id":"PMC_25009690","title":"RCAN1 regulates mitochondrial function and increases susceptibility to oxidative stress in mammalian cells.","date":"2014","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/25009690","citation_count":25,"is_preprint":false},{"pmid":"32122140","id":"PMC_32122140","title":"Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.","date":"2020","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/32122140","citation_count":25,"is_preprint":false},{"pmid":"19124655","id":"PMC_19124655","title":"Rcan1 negatively regulates Fc epsilonRI-mediated signaling and mast cell function.","date":"2009","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19124655","citation_count":24,"is_preprint":false},{"pmid":"11080588","id":"PMC_11080588","title":"The murine DSCR1-like (Down syndrome candidate region 1) gene family: conserved synteny with the human orthologous genes.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11080588","citation_count":24,"is_preprint":false},{"pmid":"17910944","id":"PMC_17910944","title":"Brain expression of the calcineurin inhibitor RCAN1 (Adapt78).","date":"2007","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/17910944","citation_count":22,"is_preprint":false},{"pmid":"24051307","id":"PMC_24051307","title":"A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.","date":"2013","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/24051307","citation_count":22,"is_preprint":false},{"pmid":"19725972","id":"PMC_19725972","title":"Glucocorticoid evoked upregulation of RCAN1-1 in human leukemic CEM cells susceptible to apoptosis.","date":"2009","source":"Journal of molecular signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19725972","citation_count":21,"is_preprint":false},{"pmid":"12225619","id":"PMC_12225619","title":"Mutational analyses of the signals involved in the subcellular location of DSCR1.","date":"2002","source":"BMC cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12225619","citation_count":21,"is_preprint":false},{"pmid":"18485898","id":"PMC_18485898","title":"CREB activates proteasomal degradation of DSCR1/RCAN1.","date":"2008","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18485898","citation_count":20,"is_preprint":false},{"pmid":"17596961","id":"PMC_17596961","title":"Overexpression of DSCR1 blocks zinc-induced neuronal cell death through the formation of nuclear aggregates.","date":"2007","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/17596961","citation_count":20,"is_preprint":false},{"pmid":"21890628","id":"PMC_21890628","title":"The regulator of calcineurin 1 (RCAN1/DSCR1) activates the cAMP response element-binding protein (CREB) pathway.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21890628","citation_count":20,"is_preprint":false},{"pmid":"28712932","id":"PMC_28712932","title":"Pyrrolidine dithiocarbamate (PDTC) inhibits inflammatory signaling via expression of regulator of calcineurin activity 1 (RCAN1): Anti-inflammatory mechanism of PDTC through RCAN1 induction.","date":"2017","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28712932","citation_count":19,"is_preprint":false},{"pmid":"28553204","id":"PMC_28553204","title":"Leucine-Rich Repeat Kinase 2 (LRRK2) Stimulates IL-1β-Mediated Inflammatory Signaling through Phosphorylation of RCAN1.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28553204","citation_count":19,"is_preprint":false},{"pmid":"22128263","id":"PMC_22128263","title":"Regulator of Calcineurin 1 Isoform 4 (RCAN1.4) Is Overexpressed in the Glomeruli of Diabetic Mice.","date":"2011","source":"The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22128263","citation_count":19,"is_preprint":false},{"pmid":"30267660","id":"PMC_30267660","title":"RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30267660","citation_count":19,"is_preprint":false},{"pmid":"31304631","id":"PMC_31304631","title":"DSCR1-mediated TET1 splicing regulates miR-124 expression to control adult hippocampal neurogenesis.","date":"2019","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/31304631","citation_count":18,"is_preprint":false},{"pmid":"36305917","id":"PMC_36305917","title":"RCAN1 deficiency aggravates sepsis-induced cardiac remodeling and dysfunction by accelerating mitochondrial pathological fission.","date":"2022","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/36305917","citation_count":18,"is_preprint":false},{"pmid":"17610901","id":"PMC_17610901","title":"Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.","date":"2007","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/17610901","citation_count":18,"is_preprint":false},{"pmid":"23118980","id":"PMC_23118980","title":"Covalent NEDD8 conjugation increases RCAN1 protein stability and potentiates its inhibitory action on calcineurin.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23118980","citation_count":18,"is_preprint":false},{"pmid":"12716059","id":"PMC_12716059","title":"DSCR1(Adapt78)--a Janus gene providing stress protection but causing Alzheimer's disease?","date":"2003","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/12716059","citation_count":18,"is_preprint":false},{"pmid":"39053690","id":"PMC_39053690","title":"Suppression of RCAN1 alleviated lipid accumulation and mitochondrial fission in diabetic cardiomyopathy.","date":"2024","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/39053690","citation_count":17,"is_preprint":false},{"pmid":"24218457","id":"PMC_24218457","title":"Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.","date":"2013","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24218457","citation_count":17,"is_preprint":false},{"pmid":"15906378","id":"PMC_15906378","title":"Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15906378","citation_count":17,"is_preprint":false},{"pmid":"18575781","id":"PMC_18575781","title":"Oxidative stress-induced ubiquitination of RCAN1 mediated by SCFbeta-TrCP ubiquitin ligase.","date":"2008","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18575781","citation_count":16,"is_preprint":false},{"pmid":"23150431","id":"PMC_23150431","title":"CREB-mediated Bcl-2 expression contributes to RCAN1 protection from hydrogen peroxide-induced neuronal death.","date":"2013","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23150431","citation_count":16,"is_preprint":false},{"pmid":"28061453","id":"PMC_28061453","title":"The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28061453","citation_count":16,"is_preprint":false},{"pmid":"18840614","id":"PMC_18840614","title":"Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18840614","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50468,"output_tokens":9955,"usd":0.150365},"stage2":{"model":"claude-opus-4-6","input_tokens":13996,"output_tokens":4148,"usd":0.26052},"total_usd":0.410885,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"RCAN1 (DSCR1) physically interacts with and inhibits calcineurin A (the catalytic subunit of PP2B/calcineurin). The RCAN1 binding region in calcineurin A is located in the linker region between the catalytic domain and the calcineurin B binding domain, outside other previously defined functional domains. Overexpression of RCAN1 inhibits calcineurin-dependent gene transcription through inhibition of NFAT nuclear translocation.\",\n      \"method\": \"Co-immunoprecipitation, functional transcription assays, domain mapping\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal binding, domain mapping, and functional transcriptional readout; replicated across multiple subsequent studies\",\n      \"pmids\": [\"10861295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DSCR1 (RCAN1) and DYRK1A act synergistically to prevent nuclear occupancy of NFATc transcription factors. Mathematical modelling and mouse genetic experiments (calcineurin- and Nfatc-deficient mice, Dscr1- and Dyrk1a-overexpressing mice) show that 1.5-fold increase in dosage of DSCR1 and DYRK1A cooperatively destabilizes the NFAT regulatory circuit.\",\n      \"method\": \"Genetic mouse models (KO, transgenic overexpression), mathematical modelling, nuclear localization assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic and biochemical approaches, high-citation foundational study\",\n      \"pmids\": [\"16554754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RCAN1 suppresses VEGF-mediated angiogenic signaling by inhibiting the calcineurin pathway in endothelial cells. A single extra transgenic copy of Dscr1 suppresses tumor growth through a deficit in tumor angiogenesis. Additionally, RCAN1 and DYRK1A together may markedly diminish angiogenesis.\",\n      \"method\": \"Transgenic mouse models, tumor xenograft assays, genetic KO experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple mouse models with defined cellular phenotype (angiogenesis suppression), high-citation study\",\n      \"pmids\": [\"19458618\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DSCR1 (RCAN1) is a VEGF target gene in endothelial cells. DSCR1 expression blocks dephosphorylation, nuclear translocation, and transcriptional activity of NFAT, forming a negative feedback loop with calcineurin signaling. Knockdown of endogenous DSCR1 increases NFAT activity and stimulates expression of inflammatory genes (tissue factor, E-selectin, Cox-2).\",\n      \"method\": \"siRNA knockdown, NFAT reporter assays, genome-wide gene expression analysis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain- and loss-of-function with defined molecular readouts\",\n      \"pmids\": [\"15016650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RCAN1 interacts with TAB2 (identified by yeast two-hybrid screen), recruiting TAK1, TAB1, and calcineurin into a macromolecular signalling complex. TAK1 phosphorylates RCAN1 at Ser94 and Ser136, converting RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signalling and enhancing NFATc1 nuclear translocation and cardiomyocyte hypertrophic growth. Calcineurin activation in turn dephosphorylates and inhibits TAK1 and TAB1.\",\n      \"method\": \"Yeast two-hybrid, Co-IP, in vitro phosphorylation assay, MEF KO cultures, cardiomyocyte hypertrophy assay\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — yeast two-hybrid identification confirmed by Co-IP, in vitro kinase assay with site-specific mutagenesis, genetic KO validation\",\n      \"pmids\": [\"19136967\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dyrk1A directly interacts with and phosphorylates RCAN1 at Ser112 and Thr192. Dyrk1A-mediated phosphorylation at Ser112 primes RCAN1 for GSK3β-mediated phosphorylation at Ser108. Phosphorylation at Thr192 enhances RCAN1 binding to calcineurin, potentiating its inhibitory activity, leading to reduced NFAT transcriptional activity and enhanced tau phosphorylation.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, site-directed mutagenesis, NFAT reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with mutagenesis and functional downstream readouts\",\n      \"pmids\": [\"21965663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"A small peptide fragment of DSCR1 competitively inhibits calcineurin phosphatase activity in vitro and in vivo, identifying the minimal calcineurin-inhibitory domain of RCAN1.\",\n      \"method\": \"In vitro calcineurin activity assay, in vivo inhibition assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with defined peptide fragment\",\n      \"pmids\": [\"16131541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Targeted deletion of both DSCR1 isoforms leads to hyperactivated calcineurin and precocious endothelial apoptosis, inhibiting formation of an effective tumor vasculature. Pharmacological calcineurin inhibition (cyclosporin A) rescues the endothelial defect in DSCR1-/- mice, restoring tumor growth. The DSCR1.Ex4 isoform suppresses calcineurin-NFAT signaling blocking endothelial proliferation, while the DSCR1.Ex1 isoform may promote angiogenesis.\",\n      \"method\": \"Genetic KO mouse model, tumor xenograft, pharmacological rescue with cyclosporin A\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype, isoform-specific effects, pharmacological epistasis\",\n      \"pmids\": [\"18455125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"RCAN1 knockout mice exhibit deficits in spatial learning and memory, reduced associative cued memory, and impaired late-phase LTP, phenotypes similar to transgenic mice with increased calcineurin activity. RCAN1 KO mice display increased calcineurin activity, increased abundance of a cleaved calcineurin fragment, and decreased phosphorylation of the calcineurin substrate DARPP-32.\",\n      \"method\": \"RCAN1 knockout mouse behavioral testing, electrophysiology (L-LTP), calcineurin activity assay, western blotting\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple behavioral, electrophysiological, and biochemical readouts\",\n      \"pmids\": [\"18045910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RCAN1 protein is degraded through two distinct pathways: the ubiquitin proteasome pathway and chaperone-mediated autophagy (CMA). Two CMA recognition motifs were identified in the RCAN1 protein. Inhibition of RCAN1 degradation reduces calcineurin-NFAT activity.\",\n      \"method\": \"Lysosomal inhibitor assays, macroautophagy inhibition, CMA disruption, promoter assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple pharmacological approaches with functional readout; single lab\",\n      \"pmids\": [\"19509306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RCAN1 is a novel ATF6-inducible gene. Activated ATF6 induces RCAN1 promoter activity, upregulates RCAN1 mRNA, inhibits calcineurin phosphatase activity, and exerts a growth-modulating effect in cardiac myocytes that is inhibited by RCAN1-targeted siRNA, linking ER stress signaling to calcineurin-NFAT pathway regulation.\",\n      \"method\": \"ATF6 transgenic mouse model, adenoviral overexpression, RCAN1 promoter-reporter assay, siRNA knockdown, calcineurin activity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo transgenic model combined with cell-based promoter assay, siRNA knockdown, and enzymatic activity assay\",\n      \"pmids\": [\"18319259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"RCAN1/DSCR1 regulates vesicle exocytosis and fusion pore kinetics in chromaffin cells. Rcan1 controls the number of vesicles undergoing exocytosis and the speed at which the vesicle fusion pore opens and closes, independent of Ca2+ entry or readily releasable vesicle pool size. Acute calcineurin inhibition did not replicate the effect of RCAN1 overexpression.\",\n      \"method\": \"Carbon fibre amperometry in chromaffin cells from Rcan1 KO and RCAN1-overexpressing mice\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct electrophysiological measurement in complementary KO and overexpression models\",\n      \"pmids\": [\"18180251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RCAN1 overexpression in primary neurons activates caspase-9 and caspase-3, inducing neuronal apoptosis. This neurotoxicity is inhibited in caspase-3 knockout neurons. RCAN1-1 expression can be activated by dexamethasone through a functional glucocorticoid response element in the RCAN1-1 promoter.\",\n      \"method\": \"Primary neuron transfection, caspase activation assay, caspase-3 KO neurons, promoter reporter assay, ChIP\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with genetic KO rescue and defined apoptotic pathway\",\n      \"pmids\": [\"21216952\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RCAN1 (DSCR1) interacts with FMRP and regulates both dendritic spine morphogenesis and local protein synthesis. Decreasing FMRP levels restores the DSCR1-induced changes in dendritic spine morphology, placing DSCR1 as a novel regulator of FMRP.\",\n      \"method\": \"Co-immunoprecipitation, dendritic spine imaging, local protein synthesis assay, genetic epistasis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP with functional spine morphology and protein synthesis readouts, single lab\",\n      \"pmids\": [\"22863780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RCAN1 increases the expression and activity of GSK-3β at a post-transcriptional level. RCAN1-1S isoform correlates with GSK-3β levels in human brain, suggesting RCAN1 modulates the calcineurin-GSK-3β equilibrium.\",\n      \"method\": \"Tet-off regulated RCAN1 transgene, Western blotting, microarray, isoform-specific analysis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, regulated transgene expression with Western blot readout; no direct mechanistic link established\",\n      \"pmids\": [\"16649988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Amyloid-β upregulates RCAN1 expression through oxidative stress. RCAN1 proteins then inhibit calcineurin (a tau phosphatase) and induce expression of GSK-3β (a tau kinase), linking Aβ toxicity to tau hyperphosphorylation. Silencing RCAN1 prevents Aβ-induced tau hyperphosphorylation.\",\n      \"method\": \"Primary cortical neuron culture, siRNA knockdown, antioxidant treatment, tau phosphorylation western blot\",\n      \"journal\": \"Journal of Alzheimer's disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional rescue via RCAN1 silencing with defined pathway placement; single lab\",\n      \"pmids\": [\"21876249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"RCAN1-1L induces mitochondrial autophagy (mitophagy) through adenine nucleotide translocator-dependent mitochondrial permeability transition pore opening, and shifts cellular bioenergetics from aerobic respiration to glycolysis.\",\n      \"method\": \"Tet-regulated transgene induction, mitochondrial fractionation, mitophagy assays, metabolic assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — regulated transgene with multiple mitochondrial functional readouts; single lab\",\n      \"pmids\": [\"22389495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Excess RCAN1 impairs neurotrophic support of sympathetic neurons by inhibiting calcineurin-dependent endocytosis of the NGF receptor TrkA. Genetically correcting RCAN1 levels in Down syndrome mice improves NGF-dependent receptor trafficking, neuronal survival, and innervation.\",\n      \"method\": \"Genetic mouse models (Down syndrome Ts65Dn), live-cell TrkA trafficking assays, genetic rescue of RCAN1 dosage\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct receptor trafficking experiment with genetic rescue, clear mechanism defined\",\n      \"pmids\": [\"26658127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Increased dosage of DSCR1 cooperates with DYRK1A to suppress NFATc transcription factor activity in neural progenitors, causing a delay in neuronal differentiation and alteration of laminar fate in the developing neocortex. Counteracting the dysregulated pathway ameliorates delayed neuronal differentiation in Ts1Cje Down syndrome mice.\",\n      \"method\": \"In utero electroporation, Ts1Cje mouse model, NFAT reporter assay, genetic epistasis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with in vivo neural progenitor functional readouts\",\n      \"pmids\": [\"24352425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RCAN1 controls axon outgrowth by modulating growth cone actin dynamics through regulation of cofilin phosphorylation (phospho/dephospho-cofilin). Additionally, DSCR1 mediates BDNF-induced local protein synthesis and growth cone turning.\",\n      \"method\": \"Live imaging, cofilin phosphorylation assays, DSCR1 KO and overexpression, growth cone turning assay\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cofilin phosphorylation measurement with functional growth cone assays; single lab\",\n      \"pmids\": [\"27185837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RCAN1 maintains a more fused mitochondrial network by inhibiting calcineurin-dependent activation of the fission protein DRP1. In RCAN1-depleted cardiomyocytes, increased CN activity promotes DRP1-mediated fragmentation, reduces mitochondrial membrane potential and Ca2+ buffering capacity, and increases susceptibility to ischemia/reperfusion injury.\",\n      \"method\": \"Cardiomyocyte RCAN1 KO and adenoviral overexpression, mitochondrial morphology imaging, O2 consumption assay, I/R injury model, pharmacological DRP1 and calcineurin inhibition\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementary KO and overexpression with pharmacological rescue and multiple functional readouts\",\n      \"pmids\": [\"29362227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NEDD8 is conjugated to RCAN1 (RCAN1-1S) at lysine residues K96, K104, and K107. Neddylation enhances RCAN1 protein stability by inhibiting proteasomal degradation, increases RCAN1 binding to calcineurin, and potentiates RCAN1 inhibitory activity toward downstream NFAT signaling.\",\n      \"method\": \"NEDD8 conjugation assay, mutagenesis of lysine residues, co-immunoprecipitation, NFAT reporter assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — PTM mapped to specific residues with functional calcineurin-binding and NFAT readouts; single lab\",\n      \"pmids\": [\"23118980\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Oxidative stress (H2O2) induces SCFβ-TrCP ubiquitin ligase-mediated ubiquitination of RCAN1, leading to its proteasomal degradation. β-TrCP interacts with RCAN1 in response to H2O2, and siRNA knockdown of β-TrCP abolishes H2O2-induced RCAN1 decrease.\",\n      \"method\": \"In vitro ubiquitination assay, co-immunoprecipitation, siRNA knockdown, western blotting\",\n      \"journal\": \"International journal of molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro ubiquitination assay combined with siRNA rescue; single lab\",\n      \"pmids\": [\"18575781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CREB activates proteasomal degradation of RCAN1/DSCR1 through the ubiquitin-proteasome pathway. CREB enhances ubiquitination and increases the turnover rate of RCAN1, and this requires CREB's transcriptional activation domain.\",\n      \"method\": \"Proteasome inhibitor experiments, ubiquitination assay, CREB overexpression and dominant-negative constructs, pulse-chase analysis\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined E3 pathway with multiple supporting assays; single lab\",\n      \"pmids\": [\"18485898\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Raf-1 is a binding partner of DSCR1. Two Raf-1 binding regions exist in DSCR1: one in the N-terminus and one in the C-terminus. Calpain cleavage of DSCR1 generates fragments with differential binding affinity to Raf-1 versus calcineurin.\",\n      \"method\": \"GST pulldown, co-immunoprecipitation, calpain cleavage assay\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single pulldown/Co-IP without functional consequence defined; single lab\",\n      \"pmids\": [\"15935327\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DSCR1 protein (calcipressin 1) protects cells against acute oxidative stress and calcium stress. Resistance to these stresses increased as a function of DSCR1/calcipressin 1 expression and decreased when gene/protein expression diminished, consistent with calcineurin inhibition being the protective mechanism.\",\n      \"method\": \"Stable transfection, tet-off regulated transgene expression, antisense oligonucleotides, cell viability assays after H2O2 and calcium ionophore A23187 challenge\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — complementary gain- and loss-of-function approaches with defined stress phenotype; single lab\",\n      \"pmids\": [\"12039863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Oxidative stress causes rapid hyperphosphorylation of DSCR1 protein. Phosphorylation of serines in the calcineurin-interacting conserved region of DSCR1 attenuates its inhibition of calcineurin, suggesting phosphorylation modulates calcineurin inhibitory activity.\",\n      \"method\": \"H2O2 treatment of cells, kinase inhibitor studies, in vitro calcineurin inhibition assay with phosphorylated peptides\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro peptide/calcineurin assay combined with cell-based phosphorylation studies; single lab\",\n      \"pmids\": [\"12927602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DSCR1 subcellular localization is preferentially nuclear, independent of isoform or cell line. A segment in the C-terminus is important for nuclear localization, and serine/threonine residues in this region regulate nuclear targeting, suggesting phosphorylation-dependent regulation of DSCR1 localization.\",\n      \"method\": \"GFP fusion constructs in multiple cell lines, deletion mutagenesis, site-directed mutagenesis\",\n      \"journal\": \"BMC cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct imaging with systematic mutagenesis in multiple cell lines; single lab\",\n      \"pmids\": [\"12225619\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RCAN1 functions as an inhibitor of calcineurin when its levels are low and as a facilitator when levels are high. Nuclear export of GSK3β, promoted by PI3K signaling, switches on the facilitative role of RCAN1 through sequential phosphorylation, forming a hidden incoherent regulatory switch.\",\n      \"method\": \"Single-cell live imaging, mathematical modelling, pharmacological PI3K inhibition, NFAT localization assays\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systems approach combining single-cell experiment with computational modelling; single lab\",\n      \"pmids\": [\"21172821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DSCR1 binds to TET1 introns to regulate splicing of TET1, modulating TET1 protein level. TET1 in turn controls demethylation of the miR-124 promoter to modulate miR-124 expression, thereby regulating adult hippocampal neurogenesis. Correcting TET1 levels in DSCR1 KO mice prevents defective adult neurogenesis.\",\n      \"method\": \"Co-IP, RNA splicing analysis, DSCR1 KO mice, TET1 level correction, adult neurogenesis assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — novel mechanism (splicing regulation) with genetic rescue; single lab\",\n      \"pmids\": [\"31304631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"RCAN1.4 expression is induced by VEGFR-2 activation in a Ca2+ and PKC-delta dependent manner. siRNA silencing of RCAN1.4 results in increased NFAT-regulated gene expression, decreased cellular migration, and disrupted tubular morphogenesis.\",\n      \"method\": \"PKC inhibitors, siRNA knockdown of PKC-delta, RCAN1.4 siRNA, endothelial cell migration and tube formation assays, NFAT reporter\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and siRNA epistasis with defined signaling pathway and cellular phenotype; single lab\",\n      \"pmids\": [\"20625401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RCAN1.4 regulates agonist-stimulated VEGFR-2 internalisation and establishment of endothelial cell polarity. siRNA silencing of RCAN1 inhibits VEGF-mediated cytoskeletal reorganisation and directed cell migration. Morpholino silencing of zebrafish RCAN1.4 orthologue disrupts vascular development.\",\n      \"method\": \"siRNA knockdown, VEGFR-2 internalization assay, cell polarity assay, migration/sprouting assays, zebrafish morpholino knockdown\",\n      \"journal\": \"Angiogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple assays in human cells plus zebrafish validation; single lab\",\n      \"pmids\": [\"28271280\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RCAN1 activates CREB phosphorylation and cAMP response element-mediated gene transcription. This CREB activation is dependent on RCAN1's ability to inhibit calcineurin activity.\",\n      \"method\": \"RCAN1 overexpression, CREB phosphorylation western blot, CRE-luciferase reporter assay, calcineurin inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — overexpression only with reporter assay, mechanism inferred from calcineurin inhibition; single lab\",\n      \"pmids\": [\"21890628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"RCAN1 (Rcan1) negatively regulates FcεRI-mediated mast cell activation by inhibiting calcineurin activity, thereby suppressing NFAT and NF-κB activation and reducing cytokine production and degranulation. Rcan1 expression in mast cells is controlled by the transcription factor Egr1 through a functional Egr1 binding site in the Rcan1 promoter.\",\n      \"method\": \"Rcan1 KO mice, mast cell calcineurin activity assay, NFAT/NF-κB reporter assays, Egr1 promoter binding (EMSA/ChIP), passive cutaneous anaphylaxis\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with multiple in vivo and in vitro functional readouts and defined transcriptional mechanism\",\n      \"pmids\": [\"19124655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RCAN1 contributes to circadian rhythmicity in cardiac protection from ischemia/reperfusion. RCAN1 KO mice lose the time-of-day difference in infarct size, while calcineurin inhibition by FK506 restores protection in PM-operated animals, placing RCAN1-calcineurin signaling as a mediator of circadian cardiac protection.\",\n      \"method\": \"RCAN1 KO and transgenic mice, timed I/R surgery, FK506 pharmacological rescue, echocardiography\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic models with pharmacological rescue; single lab\",\n      \"pmids\": [\"24838101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"RCAN1 regulates CD36 expression in macrophages and its genetic inactivation reduces atherosclerosis in Apoe-/- mice. This is mechanistically linked to diminished oxLDL uptake, resistance to oxLDL-mediated inhibition of macrophage migration, and increased anti-inflammatory marker expression. Haematopoietic Rcan1 is the key contributor, demonstrated by bone marrow transplantation.\",\n      \"method\": \"Rcan1/Apoe double KO mice, bone marrow transplantation, macrophage oxLDL uptake, CD36 expression analysis\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with bone marrow transplant to identify cellular source; single lab\",\n      \"pmids\": [\"24127415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RCAN1 overexpression in mice promotes age-dependent tau pathology and dysregulation of DRP1 activity associated with mitochondrial dysfunction and oxidative stress, identifying RCAN1 as an upstream regulator of DRP1-mediated mitochondrial fission.\",\n      \"method\": \"Brain-specific RCAN1.1S transgenic mice, tau phosphorylation assay, DRP1 activity assay, memory tests, mitochondrial function assays\",\n      \"journal\": \"Acta neuropathologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic overexpression with defined biochemical and behavioral readouts; single lab\",\n      \"pmids\": [\"26497675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LRRK2 phosphorylates RCAN1-1S, and during IL-1β treatment this promotes formation of protein complexes including Tollip-RCAN1, decreases Tollip-IRAK1 binding, increases IRAK1-TRAF6 complex formation, and enhances TAK1 activity and NF-κB transcriptional activity.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, LRRK2 overexpression, NF-κB reporter assay\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, kinase assay without mutagenesis confirmation of phosphorylation sites\",\n      \"pmids\": [\"28553204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RCAN1 interacts with IκBα and affects phosphorylation of IκBα at tyrosine 42, thereby inhibiting NF-κB signaling. The N-terminal 1-103aa of RCAN1 is sufficient for NF-κB inhibition.\",\n      \"method\": \"Co-immunoprecipitation, IκBα tyrosine phosphorylation assay, RCAN1 domain mapping, NF-κB reporter, lymphoma xenograft\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — Co-IP with limited mechanistic follow-up; single lab\",\n      \"pmids\": [\"26492364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"C/EBPβ cooperates with NFAT to regulate RCAN1-4 expression. C/EBPβ binds multiple conserved sites in the RCAN1-4 proximal promoter, directly interacts with NFAT, and is required for maximal calcineurin-induced RCAN1-4 expression. C/EBPβ can also activate RCAN1-4 expression independently of calcineurin.\",\n      \"method\": \"EMSA, ChIP, co-immunoprecipitation of C/EBPβ and NFAT, luciferase reporter assay, C/EBPβ siRNA depletion\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (EMSA, ChIP, Co-IP, reporter, siRNA) demonstrating direct protein-DNA and protein-protein interactions\",\n      \"pmids\": [\"20371871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"In Drosophila, sarah (sra, the RCAN1 ortholog) is required for normal sleep. sra sleep defects are suppressed by calcineurin (CN) mutations, placing sra and CN in a common pathway regulating sleep. Pan-neural expression of sra rescues the behavioral phenotype, indicating neuronal sra function is required.\",\n      \"method\": \"Drosophila sra mutant sleep analysis, CN subunit KO, genetic epistasis (sra;CN double mutants), pan-neural rescue\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in Drosophila ortholog with multiple CN subunit KOs; relevant conserved function\",\n      \"pmids\": [\"21900555\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"RCAN1.4 expression is suppressed by DNA methylation mediated by DNMT1 and DNMT3b in liver fibrosis. RCAN1.4 overexpression alleviates liver fibrosis through inhibition of CaN/NFAT3 signaling, while RCAN1.4 knockdown exacerbates TGF-β1-induced fibrosis.\",\n      \"method\": \"Bisulfite sequencing, ChIP assay for DNMT1/DNMT3b, rAAV8-RCAN1.4 overexpression in mouse liver, NFAT3 reporter\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-confirmed epigenetic mechanism with in vivo rescue experiment\",\n      \"pmids\": [\"31285763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DSCR1 expression stimulates SOD1 (Cu,Zn superoxide dismutase) gene expression and increases SOD1 enzyme activity in PC12 cells, identified through microarray analysis of DSCR1-regulated mRNAs.\",\n      \"method\": \"Tet-off regulated DSCR1 transgene in PC12 cells, microarray, SOD1 enzyme activity assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, microarray identification without mechanistic link between RCAN1 and SOD1\",\n      \"pmids\": [\"14718387\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RCAN1 is an endogenous inhibitor of the Ca2+/calmodulin-dependent phosphatase calcineurin, binding directly to its linker region to block NFAT dephosphorylation and nuclear translocation; its activity is bidirectionally regulated by phosphorylation (by DYRK1A at Thr192/Ser112, by TAK1 at Ser94/Ser136, and priming by GSK3β at Ser108), by post-translational modifications including neddylation (which stabilizes RCAN1 and potentiates calcineurin inhibition) and SCFβ-TrCP-mediated ubiquitination (which promotes proteasomal degradation), and by chaperone-mediated autophagy; at the cellular level RCAN1 maintains mitochondrial fusion by suppressing calcineurin-dependent DRP1 activation, regulates vesicle exocytosis and fusion pore kinetics, controls axon outgrowth through cofilin-dependent actin dynamics and local protein synthesis, modulates TrkA endocytosis to support neurotrophin signaling, regulates adult hippocampal neurogenesis through TET1 splicing and miR-124 demethylation, and acts as a dose-dependent switch in calcineurin-NFAT signaling (inhibitor at low levels, facilitator at high levels via GSK3β nuclear export), with cooperative action alongside DYRK1A to suppress NFATc activity underpinning multiple Down syndrome-associated developmental and neurodegenerative phenotypes.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RCAN1 is an endogenous regulator of the calcium/calmodulin-dependent phosphatase calcineurin, functioning as a central modulator of calcineurin-NFAT signaling across cardiovascular, immune, and neural systems. RCAN1 binds the linker region of the calcineurin A catalytic subunit via a minimal inhibitory peptide domain, blocking NFAT dephosphorylation and nuclear translocation; this inhibitory activity is enhanced by DYRK1A-mediated phosphorylation at Thr192 and by neddylation at K96/K104/K107, while TAK1 phosphorylation at Ser94/Ser136 converts RCAN1 from an inhibitor to a facilitator of calcineurin-NFAT signaling, and SCFβ-TrCP-mediated ubiquitination targets it for proteasomal degradation [PMID:10861295, PMID:21965663, PMID:23118980, PMID:19136967, PMID:18575781]. Beyond calcineurin-NFAT regulation, RCAN1 maintains mitochondrial fusion by suppressing calcineurin-dependent DRP1 activation, controls axon outgrowth through cofilin-dependent actin dynamics, regulates TrkA endocytosis for neurotrophin signaling, modulates vesicle exocytosis kinetics, and regulates adult hippocampal neurogenesis through TET1 splicing [PMID:29362227, PMID:27185837, PMID:26658127, PMID:18180251, PMID:31304631]. Cooperative overexpression of RCAN1 with DYRK1A—both encoded on chromosome 21—destabilizes NFAT signaling and underlies multiple Down syndrome-associated phenotypes including impaired neuronal differentiation, defective angiogenesis, and neurodegeneration [PMID:16554754, PMID:24352425, PMID:19458618].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of RCAN1 as a direct physical inhibitor of calcineurin resolved how an endogenous protein modulates calcineurin-NFAT signaling, establishing the core molecular function of the gene.\",\n      \"evidence\": \"Co-immunoprecipitation, domain mapping to calcineurin A linker region, and NFAT nuclear translocation/transcription assays in mammalian cells\",\n      \"pmids\": [\"10861295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the RCAN1-calcineurin interface not resolved\", \"Endogenous stoichiometry and tissue-specific regulation unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstration that RCAN1 protects cells from oxidative and calcium stress established a cytoprotective role consistent with calcineurin inhibition, and that RCAN1 localizes preferentially to the nucleus suggested compartmentalized regulation.\",\n      \"evidence\": \"Tet-off regulated transgene and antisense knockdown with stress challenge in cell lines; GFP-fusion imaging with deletion mutagenesis\",\n      \"pmids\": [\"12039863\", \"12225619\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Nuclear versus cytoplasmic functional partitioning not mechanistically dissected\", \"Phosphorylation sites controlling localization not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that RCAN1 is itself a VEGF/calcineurin target gene revealed a negative feedback loop in endothelial calcineurin-NFAT signaling, explaining how inflammatory gene expression (tissue factor, E-selectin, Cox-2) is self-limited.\",\n      \"evidence\": \"siRNA knockdown of RCAN1 in endothelial cells with NFAT reporter and genome-wide expression analysis\",\n      \"pmids\": [\"15016650\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the calcineurin-responsive elements in the RCAN1 promoter only partially mapped\", \"Contribution of individual RCAN1 isoforms to feedback not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Mapping the minimal calcineurin-inhibitory peptide within RCAN1 demonstrated that a short competitive fragment suffices for full enzymatic inhibition, defining the pharmacologically relevant domain.\",\n      \"evidence\": \"In vitro and in vivo calcineurin phosphatase activity assays with synthetic peptide fragments\",\n      \"pmids\": [\"16131541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of peptide-calcineurin complex not determined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The demonstration that 1.5-fold increases in RCAN1 and DYRK1A synergistically suppress NFAT nuclear occupancy provided a molecular explanation for Down syndrome phenotypes caused by chromosome 21 trisomy.\",\n      \"evidence\": \"Mathematical modelling combined with genetic mouse models (calcineurin/Nfatc KO, Dscr1/Dyrk1a transgenic overexpression)\",\n      \"pmids\": [\"16554754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of each gene to individual DS phenotypes not separated\", \"Whether other chromosome 21 genes modulate this circuit in vivo not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Multiple discoveries in 2008 expanded RCAN1's regulatory landscape: isoform-specific roles in angiogenesis (Ex4 inhibits, Ex1 promotes), ATF6-mediated ER stress induction linking unfolded protein response to calcineurin, SCFβ-TrCP-mediated ubiquitin-proteasomal degradation under oxidative stress, and regulation of vesicle exocytosis kinetics independent of acute calcineurin inhibition.\",\n      \"evidence\": \"RCAN1 KO mice with tumor xenograft and CsA rescue; ATF6 transgenic mice with calcineurin activity assay; in vitro ubiquitination assay with β-TrCP siRNA; carbon-fiber amperometry in chromaffin cells from KO and overexpressing mice\",\n      \"pmids\": [\"18455125\", \"18319259\", \"18575781\", \"18180251\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which RCAN1 regulates fusion pore kinetics independent of calcineurin not identified\", \"Whether ATF6-RCAN1 axis operates beyond cardiomyocytes unknown\", \"Phosphodegron recognized by β-TrCP not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"TAK1 phosphorylation of RCAN1 at Ser94/Ser136 was shown to convert RCAN1 from a calcineurin inhibitor to a facilitator, revealing a phosphorylation-dependent functional switch that promotes cardiomyocyte hypertrophy and mast cell activation, while simultaneous studies confirmed RCAN1 degradation by chaperone-mediated autophagy.\",\n      \"evidence\": \"Yeast two-hybrid identification of TAB2, Co-IP of TAK1-TAB1-RCAN1-calcineurin complex, in vitro kinase assay with mutagenesis; Rcan1 KO mast cells with calcineurin activity/NFAT/NF-κB reporters; CMA motif identification with lysosomal/macroautophagy inhibitors\",\n      \"pmids\": [\"19136967\", \"19124655\", \"19509306\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for how phosphorylation switches RCAN1 from inhibitor to facilitator unknown\", \"Whether CMA and proteasomal degradation are independently regulated not established\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"DYRK1A was shown to phosphorylate RCAN1 at Ser112 (priming for GSK3β at Ser108) and Thr192 (enhancing calcineurin binding), while systems-level modelling revealed that RCAN1 functions as a concentration-dependent switch—inhibitor at low and facilitator at high levels—governed by PI3K-driven GSK3β nuclear export.\",\n      \"evidence\": \"In vitro kinase assay with site-directed mutagenesis and NFAT reporter; single-cell live imaging with mathematical modelling and PI3K pharmacological inhibition\",\n      \"pmids\": [\"21965663\", \"21172821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo validation of the dual-switch model in specific tissues not performed\", \"Whether additional kinases contribute to the switch not explored\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Neddylation of RCAN1 at K96/K104/K107 was found to stabilize the protein and potentiate calcineurin inhibition, while RCAN1 was linked to Aβ-induced tau hyperphosphorylation through calcineurin inhibition and GSK3β upregulation, and shown to interact with FMRP to regulate dendritic spine morphogenesis and local protein synthesis.\",\n      \"evidence\": \"NEDD8 conjugation assay with lysine mutagenesis and NFAT reporter; RCAN1 siRNA rescue of Aβ-induced tau phosphorylation in primary cortical neurons; Co-IP of RCAN1-FMRP with dendritic spine imaging and genetic epistasis\",\n      \"pmids\": [\"23118980\", \"21876249\", \"22863780\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"E3 ligase responsible for RCAN1 neddylation not identified\", \"Whether FMRP interaction is calcineurin-dependent not tested\", \"Direct versus indirect mechanism of GSK3β upregulation by RCAN1 unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"RCAN1-DYRK1A cooperative suppression of NFAT was demonstrated to delay neuronal differentiation and alter cortical laminar fate in vivo, directly linking the dosage-sensitive calcineurin-NFAT circuit to Down syndrome neurodevelopmental defects.\",\n      \"evidence\": \"In utero electroporation in Ts1Cje Down syndrome mice with NFAT reporter assay and genetic epistasis\",\n      \"pmids\": [\"24352425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether postnatal correction of the RCAN1-DYRK1A imbalance rescues cortical deficits not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"RCAN1 excess was shown to impair NGF-dependent TrkA endocytosis, compromising sympathetic neuron survival and innervation in a Down syndrome mouse model, establishing receptor trafficking as a calcineurin-dependent RCAN1 function.\",\n      \"evidence\": \"Live-cell TrkA trafficking assays in Ts65Dn Down syndrome mouse sympathetic neurons with genetic correction of RCAN1 dosage\",\n      \"pmids\": [\"26658127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other receptor tyrosine kinases are similarly regulated by RCAN1-calcineurin not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"RCAN1 was found to control axon outgrowth by modulating cofilin phosphorylation and actin dynamics in growth cones, and to mediate BDNF-induced local protein synthesis and growth cone turning, defining a non-transcriptional cytoskeletal role.\",\n      \"evidence\": \"Live imaging of growth cones, cofilin phosphorylation assays, RCAN1 KO and overexpression, growth cone turning assay\",\n      \"pmids\": [\"27185837\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether cofilin regulation is calcineurin-dependent or through a separate pathway not fully resolved\", \"Mechanism of RCAN1-dependent local translation not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"RCAN1 was established as a maintainer of mitochondrial fusion in cardiomyocytes by inhibiting calcineurin-dependent DRP1 dephosphorylation and activation, with RCAN1 loss leading to mitochondrial fragmentation, impaired Ca2+ buffering, and increased ischemia/reperfusion injury.\",\n      \"evidence\": \"Cardiomyocyte RCAN1 KO and adenoviral overexpression with pharmacological DRP1/calcineurin inhibition, mitochondrial morphology imaging, and I/R injury model\",\n      \"pmids\": [\"29362227\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether RCAN1-DRP1 axis operates in non-cardiac tissues with high mitochondrial demand not tested\", \"Specific DRP1 phosphorylation site regulated by RCAN1-calcineurin not mapped\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A calcineurin-independent function was uncovered: RCAN1 binds TET1 introns to regulate TET1 splicing, controlling TET1 protein levels and downstream miR-124 promoter demethylation, thereby regulating adult hippocampal neurogenesis.\",\n      \"evidence\": \"Co-IP and RNA splicing analysis in RCAN1 KO mice, TET1 level correction rescuing adult neurogenesis defects\",\n      \"pmids\": [\"31304631\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether RCAN1-TET1 splicing regulation is direct RNA binding or mediated through a spliceosome component not determined\", \"Generality of RCAN1 splicing regulation beyond TET1 unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the atomic-resolution structure of the RCAN1-calcineurin complex, the full spectrum of calcineurin-independent RCAN1 functions, how isoform-specific and tissue-specific RCAN1 activities are coordinated, and whether therapeutic modulation of RCAN1 can ameliorate Down syndrome or neurodegeneration phenotypes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structural model of the RCAN1-calcineurin complex exists\", \"Calcineurin-independent functions (FMRP, TET1 splicing, vesicle exocytosis) lack mechanistic integration\", \"Isoform-specific roles (Ex1 vs Ex4) in angiogenesis and neurodegeneration not fully dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 4, 5, 6, 21, 28]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [4, 13]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [27]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 28, 33]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [33, 35]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 18]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [20, 36]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"complexes\": [\n      \"TAK1-TAB1-TAB2-RCAN1-calcineurin signaling complex\"\n    ],\n    \"partners\": [\n      \"PPP3CA\",\n      \"DYRK1A\",\n      \"TAB2\",\n      \"TAK1\",\n      \"FMRP\",\n      \"NEDD8\",\n      \"BTRC\",\n      \"TET1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}